Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maegaki, Y.
Right arrow Articles by Takeshita, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maegaki, Y.
Right arrow Articles by Takeshita, K.
Neurology 1999;52:172
© 1999 American Academy of Neurology
Brief Communications

Normalization of creatine kinase level during arthritis in a patient with Becker muscular dystrophy

Yoshihiro Maegaki, MD, Kaeko Ogura, MD, Yukinori Maeoka, MD and Kenzo Takeshita, MD

From the Division of Child Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago, Japan.

Address correspondence and reprint requests to Dr. Yoshihiro Maegaki, Division of Child Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, 36-1 Nishi-Machi, Yonago 683-8504, Japan.

A patient with Becker muscular dystrophy had transient arthritis. During the active illness his serum creatine kinase (CK) level normalized and serum levels of soluble interleukin 2 (IL-2) receptor, IL-6, IL-1 receptor antagonist, and soluble tumor necrosis factor receptor 2 were elevated. CK increased to his usual levels after arthritis remission whereas the levels of inflammatory cytokines and their inhibitors decreased.




This article has been cited by other articles:


Home page
 Clin. Chem.Home page
K. Saito, D. Kobayashi, M. Komatsu, T. Yajima, A. Yagihashi, Y. Ishikawa, R. Minami, and N. Watanabe
A Sensitive Assay of Tumor Necrosis Factor {alpha} in Sera from Duchenne Muscular Dystrophy Patients
Clin. Chem., October 1, 2000; 46(10): 1703 - 1704.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by AAN Enterprises, Inc.